Conclusion: This meta-analysis strongly suggests that minoxidil, finasteride, and low-level laser light therapy are effective for promoting hair growth in men with androgenetic alopecia and that minoxidil is effective in women with androgenetic alopecia.
PubMed 28396101 ↗Minoxidil
Also known as Rogaine, Oral Minoxidil
The short answer. More people than not who report on Minoxidil say it helped (65% of 45). It is most often used for skin & hair: 88% of 48 reports say that improved. It is well studied — 89 meta-analyses on PubMed.
From 91 mentions in total — the rest didn't say how it went and aren't counted.
What Minoxidil does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 89 meta-analyses on PubMed ↗ · 186 randomized trials ↗
Conclusion: CMNT significantly enhances hair count and diameter in AGA patients with mild adverse events. MN parameters including depth, duration, and technique variations did not significantly affect hair count outcome, suggesting microneedling as a promising adjunctive AGA treatment.
PubMed 40056230 ↗Conclusion: oral minoxidil, finasteride, dutasteride), and procedural (e.g. platelet-rich plasma, fractionated lasers, hair transplantation) treatments successfully promote hair growth, highlighting the superiority of a multifaceted and individualized approach to management.
PubMed 38852607 ↗Conclusion: Topical corticosteroids are the preferred first-line treatment for pediatric AA, as they hold the highest level of evidence, followed by contact immunotherapy. More clinical trials and comparative studies are needed to further guide management of pediatric AA and to promote the potential use of pre-existing, low-cost, and novel therapies, including Janus kinase inhibitors.
PubMed 33940103 ↗111 human trials on ClinicalTrials.gov test Minoxidil — 51 completed, 12 recruiting now. See all on ClinicalTrials.gov ↗
- Treatment of Androgenetic Alopecia in Men for 24 Weeks · Alopecia · 2024
- Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia · Androgenic Alopecia · 2026
- Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia · Androgenetic Alopecia, Exosomes · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “S Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil should be reserved for hypertensive patients who do not…”
9 recalls of products named for Minoxidil. Most recent:
- 2023-02-01 · Class II: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. record ↗
- 2020-08-05 · Class II: Lack of Processing Controls (lack of assurance of conformity to specifications). record ↗
- 2020-07-08 · Class I: Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
44,659 adverse-event reports mention Minoxidil. Most often reported:
- Adverse drug reaction · 8,585
- Drug ineffective · 7,760
- Alopecia · 3,801
- Application site pruritus · 2,926
- Off label use · 2,275
- Overdose · 1,461
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Minoxidil E — an unlikely cause of liver injury. LiverTox entry ↗
NIH has funded 10 research projects with Minoxidil in the title, $519,026 in total (1985–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Minoxidil ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I take about 0.5mg fin and topical min once a day before bed... noticed my hair was denser 2 months ago.”
“Honestly Oral Minoxidil is the way to go. My doctor prescribed 2.5 mg. Been on it for one month and no side effects.”
“I have had no side effects from either medication. I have been taking them for about 4 months.”
“I have also added minoxidil (rogaine) to regrow what has already been lost with noticeable success.”
Top discussions (5)
- Researchers found that a gel made from deoxyribose, a sugar found in DNA, matched minoxidil's performance, achieving 80 to 90% hair regrowth in mice with androgenetic alopecia. ↗
- If he suddenly has hair, go buy shares 📈 ↗
- I grew a full beard with Minoxidil - No one in my family has a beard ↗
- 3 months Glp3 result - 48M ↗
- DHT safe use ↗
Minoxidil compared
Other options for skin & hair
Sources
- User reports: 91 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate